Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.</li>
<li>The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.</li>
</ul>


The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.
The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.


Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Index Rebalance

Empiric Student Property / Index Rebalance

<ul>
<li>In this insight, we take a look at Quiddity's final predictions for index changes for the  F100 and F250 indices for the June 2023 Rebalance.</li>
<li>The index changes are likely to be confirmed after market close today.</li>
<li>We expect one change for the F100 index and six changes for the F250 index.</li>
</ul>


In this insight, we take a look at Quiddity's final predictions for index changes for the  F100 and F250 indices for the June 2023 Rebalance.
The index changes are likely to be confirmed after market close today.
We expect one change for the F100 index and six changes for the F250 index.


Quiddity Final Thoughts for F100/​250 June 23: Multiple High-Impact Changes Likely

United Kingdom

Videndum PLC designs, manufactures and distributes camera supports, camera mounted electronic accessories, robotic camera systems, prompters, LED lights, mobile power, monitors, bags, motion control, smart phone accessories, audio capture, and noise reduction equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Videndum (VID LN)

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

Quiddity Final Thoughts for F100/250 June 23: Multiple High-Impact Changes Likely

The F100 and F250 data cutoff has passed. The announcement of changes should come today after the London close. We see multiple high-impact...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

Quiddity Final Thoughts for F100/​250 June 23: Multiple High-Impact Changes Likely

The F100 and F250 data cutoff has passed. The announcement of changes should come today after the London close. We see multiple high-impact...

Travis Lundy

Quiddity Final Thoughts for F100/250 June 23: Multiple High-Impact Changes Likely